Not applicableWithdrawnNCT02298699What this trial is testingBiomarker for Sly Disease (MPS VII) (BioSly)Who this might be right forDevelopmental DelaySkeletal AbnormalitiesHepatomegaly+1 more CENTOGENE GmbH Rostock
Not applicableWithdrawnNCT01331642What this trial is testingBiomarker for Gaucher Disease: BioGaucher (BioGaucher)Who this might be right forSplenomegalyHepatomegaly CENTOGENE GmbH Rostock
Testing effectiveness (Phase 2)Ended earlyNCT02421354What this trial is testingNivolumab in Treating Patients With Primary Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis, or Post-Polycythemia Vera MyelofibrosisWho this might be right forHepatomegalyMyelofibrosis Transformation in Essential ThrombocythemiaPolycythemia Vera, Post-Polycythemic Myelofibrosis Phase+2 more M.D. Anderson Cancer Center 8
Not applicableNo Longer AvailableNCT00962260What this trial is testingExpanded Access Trial of Plant Expressed Recombinant Glucocerebrosidase (prGCD) in Patients With Gaucher DiseaseWho this might be right forGaucher Disease Pfizer
Testing effectiveness (Phase 2)Looking for participantsNCT03801434What this trial is testingRuxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic DisordersWho this might be right forBCR-JAK2 Fusion Protein ExpressionBlasts 20 Percent or Less of Peripheral Blood White CellsBlasts More Than 5 Percent of Bone Marrow Nucleated Cells+9 more William Shomali 10
Testing effectiveness (Phase 2)Looking for participantsNCT04988945What this trial is testingTACE and SBRT Followed by Double Immunotherapy for Downstaging Hepatocellular CarcinomaWho this might be right forHCC The University of Hong Kong 33
Not applicableUnknownNCT03666117What this trial is testingPrevalence of Hepatomegaly in Children and Adolescents With Type 1 Diabetes MellitusWho this might be right forHepatomegaly Assiut University 60
Not applicableUnknownNCT05103007What this trial is testingPVE/PVL Combined With DEB-TACE in the Treatment of Patients With Large and Unresectable Liver CancerWho this might be right forHepatocellular Carcinoma Tongji Hospital 200
Large-scale testing (Phase 3)Study completedNCT00426153What this trial is testingOctreotide in Severe Polycystic Liver DiseaseWho this might be right forPolycystic Kidney, Autosomal DominantPolycystic Liver DiseaseHepatomegaly+3 more Mayo Clinic 42
Large-scale testing (Phase 3)Study completedNCT00565097What this trial is testingLanreotide as Treatment of Polycystic LiversWho this might be right forPolycystic Liver DiseaseHepatomegalyLiver Diseases+1 more Radboud University Medical Center 38
Not applicableLooking for participantsNCT07068191What this trial is testingGepaktiv vs UDCA and Ademetionine in MAFLD With HepatomegalyWho this might be right forMetabolic Dysfunction-associated Fatty Liver Disease (MAFLD)HepatomegalyNonalcoholic Fatty Liver (NAFL)+5 more Phenomen Pharma 90
Testing effectiveness (Phase 2)Study completedNCT03499808What this trial is testingS1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary AmyloidosisWho this might be right forAmorphous, Eosinophilic, and Acellular DepositConstipationDiarrhea+10 more SWOG Cancer Research Network 43
Large-scale testing (Phase 3)UnknownNCT00771888What this trial is testingOpen-Label Extension of LOCKCYST TrialWho this might be right forPolycystic Liver DiseaseHepatomegalyLiver Diseases+2 more Radboud University Medical Center 54
Not applicableWithdrawnNCT02298634What this trial is testingBiomarker for Farber Disease (BioFarber)Who this might be right forFarber's LipogranulomatosisCeramidase DeficiencyHepatomegaly+1 more CENTOGENE GmbH Rostock